DOJ Puts Academic Medical Centers in Spotlight
Client Alert | less than 1 min read | 11.29.12
On November 27, DOJ announced that Baylor University Medical Center has agreed to pay nearly $1 million to settle whistleblower claims brought under the False Claims Act, alleging that Baylor double-billed Medicare for certain procedures and billed for more expensive services when different, less expensive services should have been billed. The settlement, which DOJ hailed as an example of increased cooperation between DOJ and HHS under the Health Care Fraud Prevention and Enforcement Action Team (HEAT) initiative, follows a string of recent cases in which DOJ has targeted higher ed institutions under the FCA.
Contacts
Insights
Client Alert | 4 min read | 04.08.26
Cosmetics Under the Microscope: FDA’s Expanding Regulatory Reach Under MoCRA
The Modernization of Cosmetics Regulation Act of 2022 (MoCRA) marked the most significant expansion of FDA’s authority over cosmetics in 80 years — and the agency is putting that authority to work. From the launch of a new adverse event reporting tool to forthcoming rules on fragrance allergens and good manufacturing practices (GMP), FDA is reshaping the regulatory landscape for manufacturers, packers, and distributors of cosmetic and personal care products.
Client Alert | 3 min read | 04.07.26
Answering the Top Seven Questions About Pending Section 301 Deadlines
Client Alert | 3 min read | 04.07.26
EU Pharma Package: Fiscal Imports in the Supply Chain Compromise Proposal
Client Alert | 5 min read | 04.07.26
